Dissolution testing poses a major challenge to the pharmaceutical, biotech and generics industries both in terms of method development and regulatory compliance.
This two-day interactive training course will explain the history, benefits, importance and role of dissolution testing in drug development today. Using practical examples and case studies throughout, delegates will gain a thorough understanding of setting and establishing specifications for optimum dissolution testing.
Eric Beyssac received a Master’s in Pharmacy and a Ph.D. degree in Pharmaceutical Technology, from the Faculty of Pharmacy, Clermont-Ferrand (France), where he is currently a Professor. He was an invited Professor at the Faculty of Pharmacy of Université Lavalin Québec from 2000 to 2002 and is still Associate Professor at this university. He is currently co-director of the research group CIDAM "Conception, Ingénierie et Développement de l'Alimentet du Medicament" (Conception, Engineering and Development of Food and Drugs). He has authored more than 35 publications in various national and international journals. His research interests include the following: In vitro in vivo correlations, sustained release drug dosage form development, and in vitro dissolution.
This course is designed for professionals working in the following areas: